Feb 17, 2011

Kimia Farma FY10 net income up 61.44%

The state-owned drug producer PT Kimia Farma Tbk (KAEF) estimated to post FY2010's net income of Rp100.9 billion, a  61.44% jump from Rp62.5 billion in the end of 2009.
Kimia Farma President Director Kimia Farma Syamsul Arifin said that such profit jump is expected to realize following the 6.31% revenue jump, from Rp2.85 trillion in 2009 to Rp3.03 trillion in the end of 2010.
Meanwhile, this year, the company seeks to record 10.89% revenue growth to Rp3.36 trillion compared to the same period in the previous year.
Syamsul said that the company owns three business units, including drug stores, trading and manufacture industry. Until now the contribution from sales is still higher compared to drug stores and trading. For the profit, manufacture industry somehow still dominates.
“In term of sales, the biggest contributors are trading and distribution while in terms of profit the industrial sector gave the biggest contribution up to 77%,” he explained.

Disclosure: No position at the stock mentioned above.

Print This Article

No comments: